Theravance Biopharma (TBPH) Tops Q3 EPS by 19c

November 8, 2016 4:30 PM EST
Get Alerts TBPH Hot Sheet
Trade TBPH Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Theravance Biopharma (NASDAQ: TBPH) reported Q3 EPS of ($0.73), $0.19 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $12.62 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment